These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9440080)
1. Lack of function of an N-ethylmaleimide-sensitive thiol protein in erythrocyte membrane of autosomal dominant polycystic kidney disease. Vareesangthip K; Wilkinson R; Thomas TH J Am Soc Nephrol; 1998 Jan; 9(1):1-8. PubMed ID: 9440080 [TBL] [Abstract][Full Text] [Related]
2. Abnormal regulation of cell membrane fluidity in diabetic nephropathy. Jones SC; Thomas TH; Marshall SM Diabetologia; 1998 Mar; 41(3):337-42. PubMed ID: 9541175 [TBL] [Abstract][Full Text] [Related]
3. Alterations in erythrocyte membrane fluidity in children with trisomy 21: a fluorescence study. Kantar A; Giorgi PL; Curatola G; Fiorini R Biol Cell; 1992; 75(2):135-8. PubMed ID: 1393150 [TBL] [Abstract][Full Text] [Related]
4. Abnormal thiol group modulation of sodium-lithium countertransport and membrane fluidity is associated with a disturbed relationship between serum triacylglycerols and membrane function in type II diabetes. Senior PA; Thomas TH; Marshall SM Clin Sci (Lond); 2000 Jun; 98(6):673-80. PubMed ID: 10814604 [TBL] [Abstract][Full Text] [Related]
5. Abnormal effect of thiol groups on erythrocyte Na/Li countertransport kinetics in adult polycystic kidney disease. Vareesangthip K; Thomas TH; Wilkinson R Nephrol Dial Transplant; 1995 Dec; 10(12):2219-23. PubMed ID: 8808214 [TBL] [Abstract][Full Text] [Related]
6. Increased human erythrocyte sodium-lithium countertransport in hyperlipidaemic patients may indicate increased membrane lipid fluidity. Dowd A; Thomas TH; Wilkinson R Eur J Clin Invest; 1993 Feb; 23(2):102-7. PubMed ID: 8489643 [TBL] [Abstract][Full Text] [Related]
7. Altered membrane microviscosity in essential hypertension: relationship with family history of hypertension and sodium-lithium countertransport activity. Carr SJ; Sikand K; Moore D; Norman RI J Hypertens; 1995 Jan; 13(1):139-46. PubMed ID: 7759844 [TBL] [Abstract][Full Text] [Related]
9. Plasma membrane fluidity of keratinocytes of normal and psoriatic skin: a study using fluorescence anisotropy of trimethylammoniumdiphenylhexatriene (TMA-DPH). Simonetti O; Ferretti G; Offidani AM; Gervasi P; Curatola G; Bossi G Arch Dermatol Res; 1996; 288(1):51-4. PubMed ID: 8750935 [TBL] [Abstract][Full Text] [Related]
10. Asymmetry of membrane fluidity in the lipid bilayer of blood platelets: fluorescence study with diphenylhexatriene and analogs. Kitagawa S; Matsubayashi M; Kotani K; Usui K; Kametani F J Membr Biol; 1991 Feb; 119(3):221-7. PubMed ID: 2056522 [TBL] [Abstract][Full Text] [Related]
11. Membrane fluidity changes in P. berghei-infected erythrocytes, investigated with a specific plasma membrane fluorescent probe. Deguercy A; Schrevel J; Duportail G; Laustriat G; Kuhry JG Biochem Int; 1986 Jan; 12(1):21-31. PubMed ID: 3511915 [TBL] [Abstract][Full Text] [Related]
12. Thiol group control of sodium-lithium countertransport kinetics in uraemia: evidence of a membrane abnormality affected by haemodialysis. Rutherford PA; Thomas TH; O'Kelly J; West IC; Wilkinson R Nephron; 1996; 72(2):184-8. PubMed ID: 8684524 [TBL] [Abstract][Full Text] [Related]
13. Ethnic differences in erythrocyte membrane fluidity and the association with serum triacylglycerols. Miller MA; Sagnella GA; Markandu ND; MacGregor GA Clin Sci (Lond); 2001 Jun; 100(6):653-8. PubMed ID: 11352781 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of antiepileptic drug effect on membrane fluidity. Tangorra A; Curatola G; Bertoli E Exp Mol Pathol; 1991 Oct; 55(2):180-9. PubMed ID: 1936213 [TBL] [Abstract][Full Text] [Related]
15. Properties of a phosphatidylcholine derivative of diphenyl hexatriene (DPH-PC) in lymphocyte membranes. A comparison with DPH and the cationic derivative TMA-DPH using static and dynamic fluorescence. Ferretti G; Tangorra A; Zolese G; Curatola G Membr Biochem; 1993; 10(1):17-27. PubMed ID: 8510559 [TBL] [Abstract][Full Text] [Related]
16. Developmental changes in synaptic membrane fluidity: a comparison of 1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-[4-(trimethylamino)phenyl]-6-phenyl-1,3,5-hexatriene (TMA-DPH). Hitzemann RJ; Harris RA Brain Res; 1984 May; 316(1):113-20. PubMed ID: 6733531 [TBL] [Abstract][Full Text] [Related]
17. The physical state of the erythrocyte membrane in myotonic dystrophy. Beaugé F; Gallay J; Sydow O; Stibler H J Neurol Sci; 1989 Oct; 93(1):93-103. PubMed ID: 2809632 [TBL] [Abstract][Full Text] [Related]
18. DPH Probe Method for Liposome-Membrane Fluidity Determination. He W Methods Mol Biol; 2023; 2622():241-244. PubMed ID: 36781766 [TBL] [Abstract][Full Text] [Related]
19. Hemolysis of erythrocytes and erythrocyte membrane fluidity changes by new lysosomotropic compounds. Kleszczyńska H; Bonarska D; Luczyński J; Witek S; Sarapuk J J Fluoresc; 2005 Mar; 15(2):137-41. PubMed ID: 15883768 [TBL] [Abstract][Full Text] [Related]
20. Transbilayer transport of a propyltrimethylammonium derivative of diphenylhexatriene (TMAP-DPH) in bovine blood platelets and adrenal chromaffin cells. Kitagawa S; Tachikawa E; Kashimoto T J Pharm Pharmacol; 2002 Dec; 54(12):1631-6. PubMed ID: 12542892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]